Literature DB >> 17165640

The metabolic syndrome: concepts and controversy.

Lewis W Johnson1, Ruth S Weinstock.   

Abstract

The metabolic syndrome is an insulin-resistant state characterized by a cluster of cardiovascular risk factors, including various combinations of abdominal obesity, glucose intolerance, hypertension, and atherogenic dyslipidemia (elevated triglyceride values, low high-density lipoprotein cholesterol levels, and small dense low-density lipoprotein cholesterol particles). The current epidemic of obesity and physical inactivity has led to an increased prevalence of this disorder. In this review, we discuss the history and pathogenesis of the metabolic syndrome, the controversy regarding the appropriateness of considering it a distinct diagnosis, and the importance of lifestyle modification in its prevention and treatment. The need for all cardiovascular risk factors to be treated, whether or not they are components of the metabolic syndrome, is emphasized. Recent discussions in the literature regarding the continued use of the term metabolic syndrome should be considered a healthy academic debate that hopefully will stimulate Ideas and innovative research to improve patient care.

Entities:  

Mesh:

Year:  2006        PMID: 17165640     DOI: 10.4065/81.12.1615

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  20 in total

1.  Regular physical activity moderates cardiometabolic risk in Alzheimer's caregivers.

Authors:  Roland von Känel; Brent T Mausbach; Joel E Dimsdale; Paul J Mills; Thomas L Patterson; Sonia Ancoli-Israel; Michael G Ziegler; Susan K Roepke; Alexandrea L Harmell; Matthew Allison; Igor Grant
Journal:  Med Sci Sports Exerc       Date:  2011-01       Impact factor: 5.411

2.  Illuminating the molecular basis for some antipsychotic drug-induced metabolic burden.

Authors:  Herbert Y Meltzer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

3.  Metabolic syndrome is associated with increased prevalence of advanced colorectal polyps.

Authors:  S Tal; E Melzer; T Chsherbakov; S Malnick
Journal:  J Nutr Health Aging       Date:  2014-01       Impact factor: 4.075

4.  Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese.

Authors:  Chung-Huang Tsai; Tsai-Chung Li; Cheng-Chieh Lin; Hsin-Sheng Tsay
Journal:  Endocrine       Date:  2011-04-16       Impact factor: 3.633

5.  Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function.

Authors:  Jing Li; Andreas J Flammer; Ryan J Lennon; Rebecca E Nelson; Rajiv Gulati; Paul A Friedman; Randal J Thomas; Nicole P Sandhu; Qi Hua; Lilach O Lerman; Amir Lerman
Journal:  Mayo Clin Proc       Date:  2012-09-12       Impact factor: 7.616

6.  In-Hospital Mortality and Post-Surgical Complications Among Cancer Patients with Metabolic Syndrome.

Authors:  Tomi Akinyemiju; Swati Sakhuja; Neomi Vin-Raviv
Journal:  Obes Surg       Date:  2018-03       Impact factor: 4.129

7.  Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis.

Authors:  Smriti K Raychaudhuri; Sidhartha Chatterjee; Caroline Nguyen; Manpreet Kaur; Ishwarlal Jialal; Siba P Raychaudhuri
Journal:  Metab Syndr Relat Disord       Date:  2010-08       Impact factor: 1.894

Review 8.  High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome.

Authors:  R A Wilke
Journal:  Pharmacogenomics J       Date:  2010-12-14       Impact factor: 3.550

Review 9.  Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.

Authors:  Tim C M A Schreuder; Bart J Verwer; Carin M J van Nieuwkerk; Chris J J Mulder
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

10.  Self-reported sleep duration is associated with the metabolic syndrome in midlife adults.

Authors:  Martica H Hall; Matthew F Muldoon; J Richard Jennings; Daniel J Buysse; Janine D Flory; Stephen B Manuck
Journal:  Sleep       Date:  2008-05       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.